NCT02919787 2024-11-20
Nordic Pancreatic Cancer Trial (NorPACT) - 1
Oslo University Hospital
Phase 2/3 Active not recruiting
Clinical Trials
9 trialsNCT04393584 2021-04-13
RusGCG-01
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
NCT02172976 2020-09-02
Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma
Krankenhaus Nordwest
Phase 2/3 Completed
NCT00952029 2020-03-30
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT03175016 2017-06-27
DEBIRI-CRLM
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Unknown
NCT01523431 2017-03-30
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase 2/3 Completed
NCT00639327 2011-06-28
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Phase 2/3 Completed
NCT01308632 2011-03-04
Metronomic Temozolamide in Patients With Recurrent Glioblastoma
Grupo Español de Investigación en Neurooncología
Phase 2/3 Unknown
NCT00192712 2010-11-10
Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer
Rambam Health Care Campus
Phase 2/3 Completed